Collegium Pharmaceutical (COLL) Current Leases (2019 - 2026)

Collegium Pharmaceutical's Current Leases history runs 8 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Current Leases rose 11.12% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 11.12% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 10.7% from the prior year.
• Current Leases rose to $1.4 million in Q1 2026 per COLL's latest filing, from $1.4 million in the prior quarter.
• Across five years, Current Leases topped out at $1.4 million in Q1 2026 and bottomed at $963000.0 in Q3 2023.
• The 5-year median for Current Leases is $1.2 million (2022), against an average of $1.2 million.
• Across the five-year window, Current Leases surged 57.07% in 2022 and decreased 19.82% in 2023, its largest moves.
• Year by year, Current Leases stood at $1.1 million in 2022, then fell by 11.15% to $988000.0 in 2023, then increased by 28.64% to $1.3 million in 2024, then gained by 10.7% to $1.4 million in 2025, then rose by 2.99% to $1.4 million in 2026.
• Per Business Quant, the three latest COLL Current Leases figures stand at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025).